Sacituzumab govitecan for metastatic breast cancer: the TROPiCS-02 trial

Saved in:
Bibliographic Details
Published in:The Lancet (British edition) 2024-07, Vol.404 (10450), p.339-339
Main Authors: Harada, Kayo, Ozaki, Akihiko, Tanimoto, Tetsuya
Format: Article
Language:English
Subjects:
Antibodies, Monoclonal, Humanized - therapeutic use
Antineoplastic Agents, Immunological - therapeutic use
Breast cancer
Breast Neoplasms - drug therapy
Breast Neoplasms - pathology
Camptothecin - administration & dosage
Camptothecin - analogs & derivatives
Camptothecin - therapeutic use
Cancer therapies
Cyclin-dependent kinases
Endocrine therapy
Female
Humans
Immunoconjugates
Kinases
Metastases
Metastasis
Neoplasm Metastasis
Tropical environments
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0140-6736
1474-547X
1474-547X
DOI:10.1016/S0140-6736(24)01048-1